369 related articles for article (PubMed ID: 22841998)
1. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
[TBL] [Abstract][Full Text] [Related]
2. [Study of the effect of surface-active agents on living cells, used as component parts in microemulsions, based on their chemical structures and critical micelle-formative concentration (CMC)].
Ujhelyi Z; Vecsernyés M; Bácskay I
Acta Pharm Hung; 2013; 83(1):3-11. PubMed ID: 23821837
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
4. Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.
Sha X; Yan G; Wu Y; Li J; Fang X
Eur J Pharm Sci; 2005 Apr; 24(5):477-86. PubMed ID: 15784337
[TBL] [Abstract][Full Text] [Related]
5. Enhancing effect of surfactants on fexofenadine.HCl transport across the human nasal epithelial cell monolayer.
Lin H; Gebhardt M; Bian S; Kwon KA; Shim CK; Chung SJ; Kim DD
Int J Pharm; 2007 Feb; 330(1-2):23-31. PubMed ID: 16997520
[TBL] [Abstract][Full Text] [Related]
6. [Formulation and characetization of self-microemulsifying drug delivery systems according to their cytotoxic attributes].
Ujhelyi Z; Vecsernyés M; Bácskay I
Acta Pharm Hung; 2014; 84(2):69-76. PubMed ID: 25167702
[TBL] [Abstract][Full Text] [Related]
7. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
8. Role of 99mTc-mannitol and 99mTc-PEG in the assessment of paracellular integrity of cell monolayers.
Shah PJ; Jogani VV; Mishra P; Mishra AK; Bagchi T; Misra AR
Nucl Med Commun; 2007 Aug; 28(8):653-9. PubMed ID: 17625388
[TBL] [Abstract][Full Text] [Related]
9. Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells.
Konsoula R; Barile FA
Toxicol In Vitro; 2005 Aug; 19(5):675-84. PubMed ID: 15896555
[TBL] [Abstract][Full Text] [Related]
10. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
Dimitrijevic D; Shaw AJ; Florence AT
J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
12. Lactose oleate as new biocompatible surfactant for pharmaceutical applications.
Perinelli DR; Lucarini S; Fagioli L; Campana R; Vllasaliu D; Duranti A; Casettari L
Eur J Pharm Biopharm; 2018 Mar; 124():55-62. PubMed ID: 29258912
[TBL] [Abstract][Full Text] [Related]
13. The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system.
Nerurkar MM; Burton PS; Borchardt RT
Pharm Res; 1996 Apr; 13(4):528-34. PubMed ID: 8710741
[TBL] [Abstract][Full Text] [Related]
14. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics.
Buyukozturk F; Benneyan JC; Carrier RL
J Control Release; 2010 Feb; 142(1):22-30. PubMed ID: 19850092
[TBL] [Abstract][Full Text] [Related]
15. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
16. Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines.
Duizer E; Gilde AJ; Versantvoort CH; Groten JP
Toxicol Appl Pharmacol; 1999 Mar; 155(2):117-26. PubMed ID: 10053166
[TBL] [Abstract][Full Text] [Related]
17. Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on caco-2 cell monolayers and pig nasal mucosa.
Ekelund K; Osth K; Påhlstorp C; Björk E; Ulvenlund S; Johansson F
J Pharm Sci; 2005 Apr; 94(4):730-44. PubMed ID: 15682384
[TBL] [Abstract][Full Text] [Related]
18. Surfactants enhance the tight-junction permeability of food allergens in human intestinal epithelial Caco-2 cells.
Mine Y; Zhang JW
Int Arch Allergy Immunol; 2003 Feb; 130(2):135-42. PubMed ID: 12673067
[TBL] [Abstract][Full Text] [Related]
19. Modulation of intestinal barrier properties by miltefosine.
Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
[TBL] [Abstract][Full Text] [Related]
20. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
